NYSE:INO

Inovio Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy INO

*Your capital is at risk

$0.677

+0.0210 (+3.20%)

At Close: Jul 31, 2026

Inovio Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.86. In total, the insiders bought 2.06M and sold 75.73K INO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	91.86
● Buy	2.06M shares
● Sell	75.73K shares
84% Buy Activity Strong Negative Correlation
Buy Signal High Confidence May 20, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 91.86. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (84% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 04, 2026 Buy	Common Stock Option A-Award	Kies Peter CFO	C-Suite Officer	31 240 Value: $54.0K
Mar 04, 2026 Buy	Restricted Stock Unit A-Award	Sumner Michael John Chief Medical Officer	Officer	29 608 Value: $51.2K
Mar 04, 2026 Buy	Common Stock Option A-Award	Sumner Michael John Chief Medical Officer	Officer	36 832 Value: $63.7K
Mar 04, 2026 Buy	Common Stock Option A-Award	Humeau Laurent Chief Scientific Officer	Officer	26 840 Value: $46.4K
Mar 04, 2026 Buy	Restricted Stock Unit A-Award	Humeau Laurent Chief Scientific Officer	Officer	21 560 Value: $37.3K
Mar 04, 2026 Buy	Common Stock Option A-Award	Shea Jacqueline Elizabeth Chief Executive Officer	CEO / President	97 240 Value: $168.2K
Mar 04, 2026 Buy	Restricted Stock Unit A-Award	Shea Jacqueline Elizabeth Chief Executive Officer	CEO / President	78 760 Value: $136.3K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Weiner David B. Director	Director	972 Value: $2K
Feb 26, 2026 Buy	Common Stock M-Exempt	Weiner David B. Director	Director	972 Value: $2K
Feb 26, 2026 Buy	Common Stock M-Exempt	Humeau Laurent Chief Scientific Officer	Officer	7 366 Value: $13.2K
Feb 26, 2026 Sell	Common Stock F-InKind	Humeau Laurent Chief Scientific Officer	Officer	3 034 Value: $5K
Feb 26, 2026 Buy	Common Stock M-Exempt	Humeau Laurent Chief Scientific Officer	Officer	5 010 Value: $9K
Feb 26, 2026 Sell	Common Stock F-InKind	Humeau Laurent Chief Scientific Officer	Officer	2 064 Value: $4K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Humeau Laurent Chief Scientific Officer	Officer	7 366 Value: $13.2K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Humeau Laurent Chief Scientific Officer	Officer	5 010 Value: $9K
Feb 26, 2026 Buy	Common Stock M-Exempt	Kies Peter CFO	C-Suite Officer	10 634 Value: $19.0K
Feb 26, 2026 Sell	Common Stock F-InKind	Kies Peter CFO	C-Suite Officer	6 294 Value: $11.3K
Feb 26, 2026 Buy	Common Stock M-Exempt	Kies Peter CFO	C-Suite Officer	5 010 Value: $9K
Feb 26, 2026 Sell	Common Stock F-InKind	Kies Peter CFO	C-Suite Officer	2 965 Value: $5K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Kies Peter CFO	C-Suite Officer	10 634 Value: $19.0K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Kies Peter CFO	C-Suite Officer	5 010 Value: $9K
Feb 26, 2026 Buy	Common Stock M-Exempt	Shea Jacqueline Elizabeth Chief Executive Officer	CEO / President	28 401 Value: $50.8K
Feb 26, 2026 Sell	Common Stock F-InKind	Shea Jacqueline Elizabeth Chief Executive Officer	CEO / President	13 657 Value: $24.4K
Feb 26, 2026 Buy	Common Stock M-Exempt	Shea Jacqueline Elizabeth Chief Executive Officer	CEO / President	18 632 Value: $33.4K
Feb 26, 2026 Buy	Restricted Stock Unit M-Exempt	Sumner Michael John Chief Medical Officer	Officer	5 010 Value: $9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT INOVIO PHARMACEUTICALS

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...

Read Full Profile Here